Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol

References

• Cho NH , Shaw JE , Karuranga S , et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract . 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023 29496507
   PubMed Web of Science ®Google Scholar
• Wang L , Gao P , Zhang M , et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA . 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596 28655017
   PubMed Web of Science ®Google Scholar
• Harris MI , Klein R , Welborn TA , Knuiman MW . Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care . 1992;15(7):815–819. doi:10.2337/diacare.15.7.815 1516497
   PubMed Web of Science ®Google Scholar
• Alaboud AF , Tourkmani AM , Alharbi TJ , et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J . 2016;37(12):1408–1411. doi:10.15537/smj.2016.12.17062 27874160
   PubMed Web of Science ®Google Scholar
• Sina M , Graffy J , Simmons D . Associations between barriers to self-care and diabetes complications among patients with type 2 diabetes. Diabetes Res Clin Pract . 2018;141:126–131. doi:10.1016/j.diabres.2018.04.031 29689320
   PubMed Web of Science ®Google Scholar
• Mohammedi K , Woodward M , Marre M , et al. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol . 2017;16(1):95. doi:10.1186/s12933-017-0624-5 28750645
   PubMed Web of Science ®Google Scholar
• Karabag T , Kaya A , Temizhan A , et al. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease. Acta Diabetol . 2007;44(2):69–75. doi:10.1007/s00592-007-0245-7 17530470
   PubMed Web of Science ®Google Scholar
• Ozmen B , Boyvada S . The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy. J Diabetes Complications . 2003;17(3):128–134.12738396
   PubMed Web of Science ®Google Scholar
• Stratton IM , Adler AI , Neil HA , et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ . 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405 10938048
   PubMed Web of Science ®Google Scholar
• Lee MY , Hsiao PJ , Huang JC , Hsu WH , Chen SC , Shin SJ . Association between metabolic syndrome and micro- and macrovascular disease in type 2 diabetic mellitus. Am J Med Sci . 2018;355(4):342–349. doi:10.1016/j.amjms.2017.12.004 29661347
   PubMed Web of Science ®Google Scholar
• Lu M , Luo Y , Hu P , Dou L , Huang S . Tanshinone IIA inhibits AGEs-induced proliferation and migration of cultured vascular smooth muscle cells by suppressing ERK1/2 MAPK signaling. Iran J Basic Med Sci . 2018;21(1):83–88. doi:10.22038/IJBMS.2017.20100.5276 29372041
   PubMed Web of Science ®Google Scholar
• Golubovic-Arsovska M . Association of dyslipidaemia with macular oedema and hard exudates in diabetic maculopathy. Prilozi . 2007;28(2):149–160.18356786
   PubMedGoogle Scholar
• Cetin EN , Bulgu Y , Ozdemir S , Topsakal S , Aybek H . Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol . 2013;6(3):346–349. doi:10.3980/j.issn.2222-3959.2013.03.17 23826531
   PubMed Web of Science ®Google Scholar
• Nielsen SF , Nordestgaard BG . Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study. Lancet Diabetes Endocrinol . 2014;2(11):894–900. doi:10.1016/S2213-8587(14)70173-1 25217178
   PubMed Web of Science ®Google Scholar
• Mansi I , Frei CR , Wang CP , Mortensen EM . Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults. J Gen Intern Med . 2015;30(11):1599–1610. doi:10.1007/s11606-015-3335-1 25917657
   PubMed Web of Science ®Google Scholar
• Jialal I , Vikram NK . Inflammation and atherosclerosis: fulfilling Koch’s postulates. Ther Adv Cardiovasc Dis . 2018;12(1):5–6. doi:10.1177/1753944717744740 29187060
   PubMedGoogle Scholar
• Pouvreau C , Dayre A , Butkowski EG , Jong BD , Jelinek HF . Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res . 2018;11:61–68. doi:10.2147/JIR.S148911 29497324
   PubMed Web of Science ®Google Scholar
• Dasu MR , Devaraj S , Jialal I . High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab . 2007;293(1):E337–E346. doi:10.1152/ajpendo.00718.2006 17426109
   PubMed Web of Science ®Google Scholar
• Venugopal SK , Devaraj S , Yang T , Jialal I . Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes . 2002;51(10):3049–3054. doi:10.2337/diabetes.51.10.3049 12351446
   PubMed Web of Science ®Google Scholar
• Zoungas S , Woodward M , Li Q , et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia . 2014;57(12):2465–2474. doi:10.1007/s00125-014-3369-7 25226881
   PubMed Web of Science ®Google Scholar
• Khanam PA , Hoque S , Begum T , Habib SH , Latif ZA . Microvascular complications and their associated risk factors in type 2 diabetes mellitus. Diabetes Metab Syndr . 2017;2:S577–S581. doi:10.1016/j.dsx.2017.04.007
   Google Scholar
• Ganz T , Wainstein J , Gilad S , Limor R , Boaz M , Stern N . Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. Diabetes Metab Res Rev . 2017;33:e2836. doi:10.1002/dmrr.v33.2
   Web of Science ®Google Scholar